FDA DEVICE FACTS
Tesera-K Anterior Lumbar Interbody Fusion (ALIF) System; Tesera-K XL System; Lumbar Anchor System
Kyocera Medical Technologies, Inc.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The Kyocera Medical Technologies, Inc. (KMTI) Lumbar Anchor System is indicated for use with the KMTI Tesera-K Anterior Lumbar Interbody Fusion (ALIF) System . The KMTI Tesera-K ALIF System is indicated for interbody fusion procedures in skeletally mature patients with degenerative disc disease (DDD) in the lumbar spine at one or two contiguous levels from L2 to S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These DDD patients may have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). KMTI Tesera-K ALIF System implants are to be used with autogenous bone graft. Patients should be skeletally mature and have at least six months of non-operative treatment. Tesera-K SA ALIF cages are intended to be implanted from a direct anterior surgical approach only. Tesera-K SA ALIF cages are intended to be used with the coverplate and screws provided or with the KMTI Lumbar Anchor System. Tesera-K SA ALIF assemblies (cage, lumbar anchors, screws and coverplate) featuring one or more lumbar anchors are considered non-standalone and require supplemental fixation cleared by the FDA for use in the lumbosacral spine. The coverplate assembly is required to be used if any anchors are implanted.
Tesera-K SA ALIF cages are intended to be implanted from a direct anterior surgical approach only. Tesera-K SA ALIF cages are intended to be used with the coverplate and screws provided. Tesera-K SA ALIF assemblies (cage, screws, coverplate) that contain cages with lordotic angles less than 20° and use all four screws are standalone and require no supplemental fixation. Tesera-K SA ALIF assemblies (cage, screws, coverplate) that contain cages with lordotic angles greater than or equal to 20° or if the surgeon chose to use fewer than four screws are considered non standalone and require supplemental fixation cleared by the FDA for use in the lumbosacral spine. The Kyocera Medical Technologies, Inc. (KMTI) Tesera-K XL System is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1. KMTI Tesera-K XL System implants are to be used with autogenous or allogenic bone graft. Patients should be skeletally mature and have at least six weeks of non-operative treatment prior to implantation. The KMTI Tesera-K XL System is a non-standalone system and is required to be used with additional supplemental fixation that have been cleared by the FDA for use in the lumbar spine.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。